WHO WE ARE
Psyros Diagnostics is a new start-up established by a highly experienced team, with a proven track-record in point-of-care clinical diagnostics.
The team were the scientific core of Vivacta, a start-up acquired by Novartis in 2012 to form the Near Patient Testing Unit. This culminated in the launch of the CE-marked Niji™ Point-of-Care IVD system for measuring total IgE in 2016.
Psyros was established in 2018 to develop cutting edge diagnostics and realise our vision of transforming patients' lives, to ensure they get the right test at the right time for the right diagnosis.